[Return to Back Issues of Our
Newsletter]
For the Integrity of Disarmament Treaties
|
203-150 Wilson Street W., Ancaster, Ontario, Canada. L9G 4E7 |
Tel: (905) 648-3306 Fax: (905)
648-2563 e-mail: marklandgroup@hwcn.org web site: www.hwcn.org/link/mkg |
Recent developments relating to compliance with
multilateral treaties in the
area of disarmament and international security.
The newsletter of the Markland Group
Issue No. 18, October 2002
This newsletter was
originally published as part of the Canadian Council on International Law Bulletin,
Vol. 28, No. 2, Summer 2002.
I. Regulating Scientific Research of
Potential Relevance to Biological Warfare’, by Jonathan B. Tucker, Monterey
Institute Occasional Paper No. 8, June 2002: Reviewed by Sean Howard
II. OPCW
– Problems with Making Decisions: by Douglas Scott
Reviewed by
Sean Howard, Ph.D.*
Dr.
Jonathan B. Tucker, Director of the Chemical and Biological Weapons Program at
the Center for Nonproliferation Studies of the Monterey Institute of
International Studies, has long been a prominent advocate of concerted
international action to counter the threat of the proliferation and use of
biological weapons (BW). In the Center’s Occasional Paper No. 8 (‘After 9/11:
Preventing Mass-Destruction Terrorism and Weapons Proliferation’, Michael
Barletta, ed., June 2002), Dr. Tucker identifies the need for a new
international mechanism to regulate biotechnology research with potentially
“direct offensive applications in biological warfare”. Having argued the case for such a mechanism,
Tucker assesses the many objections likely to be raised against it.
Although
a brief review cannot do justice to the paper, its basic premise can be simply
stated: if research in such rapidly developing areas of biotechnology as
genetic engineering and plant pathology proceeds in the absence of “prudential
review” by “an international oversight regime”, there is a high risk of either
the inadvertent or deliberate development of new types and variants of BW. While
no regulatory mechanism can hope to provide watertight assurances against
accident or subterfuge, an unregulated environment – or a patchwork of uneven
national oversight systems – invites abuse and spurns the opportunity of
intervention in ill-advised or inappropriate research.
But how to
define such research? Lessons can, of course, be learnt from recent
experiments. In 2001, to give an example cited by Tucker, an Australian project
deploying genetic-modification techniques to develop a contraceptive vaccine
for mice inadvertently led to the creation of a new, virulent strain of
mousepox. Publication of such results can potentially serve as a spur to the
deliberate production of new pathogens; the gene generating the mousepox
variant, for example, interleukin-4, is common to humans, leading to
speculation it could be deployed to trigger new strains of smallpox. But
exactly what lessons should be drawn from the example? Should an oversight body
be required, or have the option, to veto all similar research? Should it rather
monitor such work, intervening in or terminating the project if necessary? Or, if similar experimental mistakes recur,
should it prohibit publication of the results? Might not open reporting of such
events prevent similar errors, or should the potential for
wilful misapplication of the
findings outweigh all other scruples?
Such
technical considerations are, of course, also political. Who should run the new
regime, and how should its performance be reviewed? How could the mechanism
simultaneously allay the fears of developing world countries that it was simply
another device to exclude them from the biotechnology sector, while respecting
the importance attached by that sector to the commercial confidentiality of its
research? Would the regime also seek to regulate state research into
‘biodefence’ against new BW? If so, why would the governments concerned agree
to risk ‘showing their hand’ by divulging potentially valuable information,
e.g. with regard to the effectiveness of existing or possible countermeasures?
If not, what credibility would the new regime have when such a major area of
advanced biotechnology fell outside its purview?
Tucker’s
intent is not to provide answers so much as encourage his readers to address
these questions. He does, however, outline the main features of any effective
system of review, arguing for a commitment by participating governments to
withhold funding or permission for “high-risk” projects until the research in
question has been approved by an independent, international scientific
oversight board. In particular, work involving “the cloning and transfer of
toxic genes and virulence factors, and the developing of antibiotic- and
vaccine-resistant strains of micro-organisms and genetically engineered toxins”
would be subject to scrutiny. As an additional safeguard, Tucker proposes that
the oversight board “establish anonymous web sites and other mechanisms to
facilitate whistle blowing by scientists who suspect that a colleague is
engaged in the development of pathogens for military purposes”. The paper also grasps the nettle of
commercial confidentiality, concluding that “proprietary industrial information
must not be exempt” from reporting requirements.
Given the
power of the oversight board to prohibit, curtail and strictly monitor
research, agreement on its scientific guidelines and operating procedures will
doubtless be a matter of vexed and protracted negotiation. Tucker concludes: “The devil will be in the
details: it will be extremely difficult to achieve consensus within the
scientific community on any regulatory mechanism.” The merit of his paper is
precisely in presenting such an honest account of the task ahead – and in his
insistence that these difficulties be weighed against the huge dangers involved
in not making the attempt.
By Douglas
Scott*
Note: An expanded version of
this article entitled Logjam in the OPCW – Time to Limit
Consensus? was published by the Acronym Institute as CWC
Special Paper No. 1 – December 2002 and appears on the Markland Group
website under the heading Markland Group Papers.
The practice of making decisions only by consensus appears to be
hampering the effectiveness of the Organization for the Prohibition of Chemical
Weapons (OPCW). When the OPCW was
established in 1997 (with a mandate to ensure the implementation of the
Chemical Weapons Convention), the treaty negotiators had agreed that its two
policy-making bodies, the Executive Council and the Conference of the States
Parties (CSP), should make decisions by two-thirds majority vote. (In the case of the CSP, the rule is
consensus if possible, otherwise two-thirds majority.)[1] Despite these provisions in the Convention, however, during the
Organization’s five-year history, with only three exceptions, all decisions by
both bodies have been made by consensus.
The exceptions were two decisions made in April 2002 calling for the
dismissal of José Bustani as Director General and one decision in 1997 relating
to the salary of the Director General of the Organization.
It appears that there is an informal understanding among all 143 States
Parties to the Chemical Weapons Convention (CWC) that decisions will normally
be made by consensus and that no State Party will stand up and call for a
vote. Diplomats at the OPCW argue that
by insisting on consensus, they are avoiding problems with compliance. If decisions are forced through Council by
majority vote, they argue, the nay-sayers are likely to refuse to comply. They point to the fact that the Organization
has had an impressive record with compliance and they want to keep it that way.
The other side of the coin is less encouraging. The policy of insisting on consensus is
causing two problems. Achieving
consensus takes time, and in the case of the OPCW, the Council is constantly
deferring important decisions. The
point has been reached where a large backlog of undecided matters has
developed. Included are matters that need
to be decided in order for the Organization to do the work mandated under the
Convention. In April 2001, Council’s
report to the CSP contained a list of 52 “matters under consideration by the
Council”. Among the items listed are:
·
Guidelines
for determining the frequency of systematic on-site inspections of facilities
where chemical weapons are stored or stockpiled pending their destruction;
·
Methodology
for selecting certain types of industrial chemical facilities for inspection;
·
Understandings
on the degree of access to be given to inspectors to review records when
inspecting certain types of facilities.
·
Guidelines
for the number, intensity, duration, timing and mode of inspection of certain
highly weapons-relevant facilities.[2]
The Council has not published a report outlining the decisions made by
it since the date of the above report.
Nevertheless, a recent periodic report issued by the Harvard Sussex
Program on the activities of the OPCW indicates that very few decisions have
been taken by the Council within the last two years. In fact, the report spoke of “the increasing paralysis in the
policy-making organs of the Organization, especially the Council.”[3] It can be assumed that most of the
52 matters on the list referred to above remain undecided, and that
responsibility for these deferrals lies mainly with the consensus policy.
The second difficulty with making decisions by consensus is that it is
likely to produce decisions that are watered down. Either they are expressed in terms that are deliberately vague or
ambiguous in order to satisfy competing interests. Or the decisions are such that they weaken the effectiveness of
the OPCW – especially in the case of decisions dealing with inspections or the
budget.
For instance, in a previous issue of Compliance Matters[4], an account is given of how the
consensus policy was responsible for the adoption of an inadequate budget for
the year 2002. Following the adoption
of this budget, it was widely predicted that the resulting shortage of funds
would mean severe cutbacks in the number of inspections performed in the year
2002. Such indeed is proving to be the
case; the Secretariat recently calculated that there will be enough money to
conduct 107 inspections in 2002 – 50% of the total inspections programmed (by
the CSP) for the year.[5]
Faced with this bleak prospect, the Executive Council is currently
considering a proposal to adopt a supplementary budget for 2002. As has happened so often in the past,
however, consensus is again interfering; the only thing the Council has been
able to agree upon as of this writing is that the budget deficit for 2002 is a
“matter of extreme concern”.
What is baffling about the craze for deciding everything by consensus is
its unanimity. Despite the fact that
any individual State Party among the 143 is entitled to call for a vote on any
issue under discussion, no such thing has ever happened.
The key to explaining this anomaly may lie in the fact that the U.S.
seems to be in the minority not only on budget matters, but on many of the
undecided issues. Such a scenario
suggests that the U.S. may have let it be known that it is insisting on all
decisions being made by consensus except where it has persuaded the required
majority to vote its way (as was the case in the two votes to dismiss
Bustani). Furthermore, it seems
possible that the U.S. has sent clear signals that any deviation from this
arrangement will result in the withdrawal of U.S. support for the OPCW and
possibly withdrawal from membership in the Treaty.
If this indeed is the U.S. position, it would explain why there has
never been a call for a vote on a resolution even when it is clear that the
substance of the resolution is supported by a two-thirds majority. The assumption seems to be that if a vote
were taken, most would feel compelled to vote with the U.S. in order to prevent
the Organization from collapsing.
This thinking probably explains the large majority that voted for the US
motion to dismiss Bustani in April 2002.
It was never clear that the required majority had agreed with the
substance of the US complaints against Bustani. Very few of the countries voting with the U.S. have explained
their vote in terms of agreeing with the complaints levelled by the U.S. against
Bustani. Most have remained silent, while
some have asserted, as Canada did unofficially, that the prime reason they
voted with the U.S. was to avoid a harmful dispute which could bring about the
downfall of the Organization.[6]
All of which suggests that, in addition to the reasons referred to above
for insisting on consensus as the method for making decisions, there is another
reason in the minds of the States Parties to the CWC, namely that the U.S. has
insisted on consensus and has made it a condition of its continued support for
the OPCW.×
* Sean Howard Ph.D. (University of Bradford) is the editor of Disarmament Diplomacy www.acronym.org.uk and Adjunct Professor in the Department of Politics, Government and Public Administration at the University College of Cape Breton. He lives in Louisbourg, Nova Scotia.
* Douglas Scott is a lawyer in Ancaster,
Ontario. He is the President of the Markland Group.
[1] Chemical Weapons Convention, Article VIII, paragraphs 18 and 29.
[2] OPCW document: EC-XXIV/3, 6 April
2001, paragraph 6, subparagraphs (l), (o), (p) and (v).
[3] Harvard Sussex Program Quarterly Review No. 34, published as part of
the Chemical and Biological Weapons Conventions Bulletin, No 52 (June 2001),
page 3.
[4] Compliance Matters, Number 16, December 2001
[5] Harvard Sussex Program Quarterly Review No. 38, in CBWCB No. 56
(June 2002), p. 12.
[6] Author’s conversation with officials at the Department of
Foreign Affairs and International Trade.